|

cabozantinib and nivolumab Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Centre Francois Baclesse1

Indications

  • Renal Cell Carcinoma (Kidney Cancer)1
  • Metastatic Renal Cell Carcinoma1
  • Locally Advanced1
  • Cancer1

Other1 trial

Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.